 | • レポートコード：D0GIR-01968 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：サービス、ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、院内感染（HAI）コントロールの世界市場を広く調査・分析し、今後の市場展望をまとめております。院内感染（HAI）コントロールの種類別市場規模（診断技術、洗浄、滅菌、治療）、用途別市場規模（総合病院、感染症病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：STERIS Corporation、Pfizer、Advanced Sterilization Products Division、Hoffmann-La Roche、Becton Dickinson ・地域別グローバル市場分析 2015年-2020年 ・院内感染（HAI）コントロールの北米市場（アメリカ、カナダ、メキシコ） ・院内感染（HAI）コントロールのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・院内感染（HAI）コントロールのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・院内感染（HAI）コントロールの南米市場（ブラジル、アルゼンチン） ・院内感染（HAI）コントロールの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：診断技術、洗浄、滅菌、治療 ・用途別分析：総合病院、感染症病院 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Hospital-acquired infections (HAIs) Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Hospital-acquired infections (HAIs) Control market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hospital-acquired infections (HAIs) Control market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hospital-acquired infections (HAIs) Control market has been segmented into:
Diagnostic techniques
Dleaning and sterilization
Treatment
By Application, Hospital-acquired infections (HAIs) Control has been segmented into:
General Hospital
Infectious Disease Hospital
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hospital-acquired infections (HAIs) Control market presented in the report. This section sheds light on the sales growth of different regional and country-level Hospital-acquired infections (HAIs) Control markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hospital-acquired infections (HAIs) Control market.
The report offers in-depth assessment of the growth and other aspects of the Hospital-acquired infections (HAIs) Control market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hospital-acquired infections (HAIs) Control Market Share Analysis
Hospital-acquired infections (HAIs) Control competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hospital-acquired infections (HAIs) Control sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hospital-acquired infections (HAIs) Control sales, revenue and market share for each player covered in this report.
The major players covered in Hospital-acquired infections (HAIs) Control are:
STERIS Corporation
Pfizer
Advanced Sterilization Products Division
Hoffmann-La Roche
Becton Dickinson
Table of Contents
1 Hospital-acquired infections (HAIs) Control Market Overview
1.1 Product Overview and Scope of Hospital-acquired infections (HAIs) Control
1.2 Classification of Hospital-acquired infections (HAIs) Control by Type
1.2.1 Global Hospital-acquired infections (HAIs) Control Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Type in 2019
1.2.3 Diagnostic techniques
1.2.4 Dleaning and sterilization
1.2.5 Treatment
1.3 Global Hospital-acquired infections (HAIs) Control Market by Application
1.3.1 Overview: Global Hospital-acquired infections (HAIs) Control Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Global Hospital-acquired infections (HAIs) Control Market by Regions
1.4.1 Global Hospital-acquired infections (HAIs) Control Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hospital-acquired infections (HAIs) Control (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hospital-acquired infections (HAIs) Control Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hospital-acquired infections (HAIs) Control Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital-acquired infections (HAIs) Control Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hospital-acquired infections (HAIs) Control Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital-acquired infections (HAIs) Control Status and Prospect (2015-2025)
2 Company Profiles
2.1 STERIS Corporation
2.1.1 STERIS Corporation Details
2.1.2 STERIS Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 STERIS Corporation SWOT Analysis
2.1.4 STERIS Corporation Product and Services
2.1.5 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2018-2019)
2.3 Advanced Sterilization Products Division
2.3.1 Advanced Sterilization Products Division Details
2.3.2 Advanced Sterilization Products Division Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Advanced Sterilization Products Division SWOT Analysis
2.3.4 Advanced Sterilization Products Division Product and Services
2.3.5 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hoffmann-La Roche
2.4.1 Hoffmann-La Roche Details
2.4.2 Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Hoffmann-La Roche SWOT Analysis
2.4.4 Hoffmann-La Roche Product and Services
2.4.5 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2018-2019)
2.5 Becton Dickinson
2.5.1 Becton Dickinson Details
2.5.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Becton Dickinson SWOT Analysis
2.5.4 Becton Dickinson Product and Services
2.5.5 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hospital-acquired infections (HAIs) Control Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital-acquired infections (HAIs) Control Players Market Share
3.2.2 Top 10 Hospital-acquired infections (HAIs) Control Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hospital-acquired infections (HAIs) Control Revenue and Market Share by Regions
4.2 North America Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
4.3 Europe Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
4.5 South America Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
5 North America Hospital-acquired infections (HAIs) Control Revenue by Countries
5.1 North America Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
5.2 USA Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
5.3 Canada Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
5.4 Mexico Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
6 Europe Hospital-acquired infections (HAIs) Control Revenue by Countries
6.1 Europe Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
6.2 Germany Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
6.3 UK Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
6.4 France Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
6.5 Russia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
6.6 Italy Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue by Countries
7.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
7.2 China Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
7.3 Japan Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
7.4 Korea Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
7.5 India Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
8 South America Hospital-acquired infections (HAIs) Control Revenue by Countries
8.1 South America Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
8.2 Brazil Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
8.3 Argentina Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hospital-acquired infections (HAIs) Control by Countries
9.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
9.3 UAE Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
9.4 Egypt Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
9.5 South Africa Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hospital-acquired infections (HAIs) Control Revenue and Market Share by Type (2015-2020)
10.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Type (2019-2024)
10.3 Diagnostic techniques Revenue Growth Rate (2015-2025)
10.4 Dleaning and sterilization Revenue Growth Rate (2015-2025)
10.5 Treatment Revenue Growth Rate (2015-2025)
11 Global Hospital-acquired infections (HAIs) Control Market Segment by Application
11.1 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Application (2015-2020)
11.2 Hospital-acquired infections (HAIs) Control Market Forecast by Application (2019-2024)
11.3 General Hospital Revenue Growth (2015-2020)
11.4 Infectious Disease Hospital Revenue Growth (2015-2020)
12 Global Hospital-acquired infections (HAIs) Control Market Size Forecast (2021-2025)
12.1 Global Hospital-acquired infections (HAIs) Control Market Size Forecast (2021-2025)
12.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Regions (2021-2025)
12.3 North America Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
12.4 Europe Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
12.6 South America Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hospital-acquired infections (HAIs) Control Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hospital-acquired infections (HAIs) Control by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hospital-acquired infections (HAIs) Control Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hospital-acquired infections (HAIs) Control Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. STERIS Corporation Corporate Information, Location and Competitors
Table 6. STERIS Corporation Hospital-acquired infections (HAIs) Control Major Business
Table 7. STERIS Corporation Hospital-acquired infections (HAIs) Control Total Revenue (USD Million) (2017-2018)
Table 8. STERIS Corporation SWOT Analysis
Table 9. STERIS Corporation Hospital-acquired infections (HAIs) Control Product and Solutions
Table 10. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Hospital-acquired infections (HAIs) Control Major Business
Table 13. Pfizer Hospital-acquired infections (HAIs) Control Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Hospital-acquired infections (HAIs) Control Product and Solutions
Table 16. Pfizer Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Advanced Sterilization Products Division Corporate Information, Location and Competitors
Table 18. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Major Business
Table 19. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Total Revenue (USD Million) (2017-2018)
Table 20. Advanced Sterilization Products Division SWOT Analysis
Table 21. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product and Solutions
Table 22. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 24. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Major Business
Table 25. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Total Revenue (USD Million) (2017-2018)
Table 26. Hoffmann-La Roche SWOT Analysis
Table 27. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product and Solutions
Table 28. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Becton Dickinson Corporate Information, Location and Competitors
Table 30. Becton Dickinson Hospital-acquired infections (HAIs) Control Major Business
Table 31. Becton Dickinson Hospital-acquired infections (HAIs) Control Total Revenue (USD Million) (2017-2018)
Table 32. Becton Dickinson SWOT Analysis
Table 33. Becton Dickinson Hospital-acquired infections (HAIs) Control Product and Solutions
Table 34. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Players (2015-2020)
Table 36. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players (2015-2020)
Table 37. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Regions (2015-2020)
Table 39. North America Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
Table 40. North America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Table 41. Europe Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Hospital-acquired infections (HAIs) Control Revenue by Countries (2015-2020)
Table 44. South America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Table 47. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) by Type (2015-2020)
Table 48. Global Hospital-acquired infections (HAIs) Control Revenue Share by Type (2015-2020)
Table 49. Global Hospital-acquired infections (HAIs) Control Revenue Forecast by Type (2021-2025)
Table 50. Global Hospital-acquired infections (HAIs) Control Revenue by Application (2015-2020)
Table 51. Global Hospital-acquired infections (HAIs) Control Revenue Share by Application (2015-2020)
Table 52. Global Hospital-acquired infections (HAIs) Control Revenue Forecast by Application (2021-2025)
Table 53. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hospital-acquired infections (HAIs) Control Picture
Figure 2. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Type in 2019
Figure 3. Diagnostic techniques Picture
Figure 4. Dleaning and sterilization Picture
Figure 5. Treatment Picture
Figure 6. Hospital-acquired infections (HAIs) Control Revenue Market Share by Application in 2019
Figure 7. General Hospital Picture
Figure 8. Infectious Disease Hospital Picture
Figure 9. Global Hospital-acquired infections (HAIs) Control Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Hospital-acquired infections (HAIs) Control Revenue Market Share in 2019
Figure 18. Global Top 10 Players Hospital-acquired infections (HAIs) Control Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Regions (2015-2020)
Figure 22. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Regions in 2018
Figure 23. North America Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 24. Europe Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 26. South America Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 28. North America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Figure 29. North America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries in 2019
Figure 30. USA Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 31. Canada Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 33. Europe Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries in 2019
Figure 35. Germany Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 36. UK Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 37. France Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 38. Russia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 39. Italy Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries in 2019
Figure 42. China Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 43. Japan Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 44. Korea Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 45. India Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 47. South America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Figure 48. South America Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries in 2019
Figure 49. Brazil Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 54. UAE Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2015-2020)
Figure 57. Global Hospital-acquired infections (HAIs) Control Revenue Share by Type (2015-2020)
Figure 58. Global Hospital-acquired infections (HAIs) Control Revenue Share by Type in 2019
Figure 59. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Type (2021-2025)
Figure 60. Global Diagnostic techniques Revenue Growth Rate (2015-2020)
Figure 61. Global Dleaning and sterilization Revenue Growth Rate (2015-2020)
Figure 62. Global Treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Hospital-acquired infections (HAIs) Control Revenue Share by Application (2015-2020)
Figure 64. Global Hospital-acquired infections (HAIs) Control Revenue Share by Application in 2019
Figure 65. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Application (2021-2025)
Figure 66. Global General Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Infectious Disease Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Hospital-acquired infections (HAIs) Control Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Hospital-acquired infections (HAIs) Control Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
Figure 72. Europe Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
Figure 74. South America Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Hospital-acquired infections (HAIs) Control Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
院内感染管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hospital Acquired Infection Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1179.1 million by 2025, from USD 1068.4 million in 2019. The …- 市中肺炎（CAP）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Community Acquired Pneumonia (CAP) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Community …
- 後天性希少血液疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acquired Orphan Blood Diseases Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The A…
- 節足動物媒介ウイルス感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Arthropod-borne Viral Infections Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 感染症迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…